Cancer Clinical Trial -Synthorx-THOR-707-101

Status:

open

ClinicalTrials.gov:

NCT04009681

A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101)

Drug

THOR-707, Checkpoint inhibitor, anti-EGFR antibody

Phase

Phase I

Condition

Solid Tumors

Keywords

Interleukin 2